Serna Bio, an AI drug discovery company pioneering RNA-targeting small molecules, today announced the members of its Scientific Advisory Board (SAB). Established in 2021, Serna Bio is a preclinical ...
PBFT02 demonstrated durable, elevated CSF PGRN levels and early evidence of reduction in plasma <a target=_blank href= ...
Revvity, Inc. , today announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for EUROIMMUN's automated chemiluminescence-based immunoassay (ChLIA) test for free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback